Pricing
Login
Home
Charts
Search
Watchlist
Products

Indoco Remedies Ltd

INDOCO
₹232.15-0.40%20 Nov 2026
Reports
Pharma Formulations

Indoco Remedies Ltd

INDOCO
₹232.15
-0.40%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,143Cr
Close
Close Price
₹232.15
Industry
Industry
Pharma Formulations
PE
Price To Earnings
67.68
PS
Price To Sales
1.12
Revenue
Revenue
₹1,909Cr
Rev Gr TTM
Revenue Growth TTM
10.64%
PAT Gr TTM
PAT Growth TTM
127.56%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
459450431433411390440485445476468520
Growth YoY
Revenue Growth YoY%
15.15.01.2-10.2-10.6-13.21.912.08.521.96.37.3
Expenses
ExpensesCr
397401384392399391422442414426426474
Operating Profit
Operating ProfitCr
6349484012-1184332504146
OPM
OPM%
13.710.911.19.32.9-0.24.08.97.110.48.88.9
Other Income
Other IncomeCr
-622122220-5410039
Interest Expense
Interest ExpenseCr
101214181618262526462827
Depreciation
DepreciationCr
242628292929303232323534
PBT
PBTCr
23337-5-31-46-37-14-31-257824
Tax
TaxCr
71155-3-40-4-2-1125
PAT
PATCr
16222-10-28-41-36-9-29-246519
Growth YoY
PAT Growth YoY%
-44.7-14.7-92.5-128.4-282.5-287.6-2,097.38.0-3.742.7280.0311.4
NPM
NPM%
3.44.90.4-2.3-6.9-10.6-8.3-1.9-6.6-5.014.03.7
EPS
EPS₹
1.72.40.2-1.1-3.1-4.5-3.9-1.0-3.2-2.67.12.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
459450431433411390440485445476468520
Growth YoY
Revenue Growth YoY%
15.15.01.2-10.2-10.6-13.21.912.08.521.96.37.3
Expenses
ExpensesCr
397401384392399391422442414426426474
Operating Profit
Operating ProfitCr
6349484012-1184332504146
OPM
OPM%
13.710.911.19.32.9-0.24.08.97.110.48.88.9
Other Income
Other IncomeCr
-622122220-5410039
Interest Expense
Interest ExpenseCr
101214181618262526462827
Depreciation
DepreciationCr
242628292929303232323534
PBT
PBTCr
23337-5-31-46-37-14-31-257824
Tax
TaxCr
71155-3-40-4-2-1125
PAT
PATCr
16222-10-28-41-36-9-29-246519
Growth YoY
PAT Growth YoY%
-44.7-14.7-92.5-128.4-282.5-287.6-2,097.38.0-3.742.7280.0311.4
NPM
NPM%
3.44.90.4-2.3-6.9-10.6-8.3-1.9-6.6-5.014.03.7
EPS
EPS₹
1.72.40.2-1.1-3.1-4.5-3.9-1.0-3.2-2.67.12.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,0081,0751,0429681,1071,2421,5411,6691,8171,6651,8451,909
Growth
Revenue Growth%
17.66.6-3.0-7.014.312.224.18.38.9-8.410.810.6
Expenses
ExpensesCr
8389189078929831,0171,2131,3831,5731,5661,7041,740
Operating Profit
Operating ProfitCr
1701561357712322432728624499142169
OPM
OPM%
16.914.612.97.911.118.121.317.113.46.07.78.8
Other Income
Other IncomeCr
245623222160137
Interest Expense
Interest ExpenseCr
1262421262214253866122127
Depreciation
DepreciationCr
616368727173797192114126133
PBT
PBTCr
999148-929132237193136-74-10746
Tax
TaxCr
17147-64398251394-814
PAT
PATCr
827741-3249315514297-78-9932
Growth
PAT Growth%
-1.1-6.0-46.6-107.1930.5285.866.4-8.1-31.8-180.4-26.6127.6
NPM
NPM%
8.17.24.0-0.32.27.510.18.55.3-4.7-5.31.7
EPS
EPS₹
8.98.44.5-0.32.610.116.815.410.5-8.5-10.73.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,0081,0751,0429681,1071,2421,5411,6691,8171,6651,8451,909
Growth
Revenue Growth%
17.66.6-3.0-7.014.312.224.18.38.9-8.410.810.6
Expenses
ExpensesCr
8389189078929831,0171,2131,3831,5731,5661,7041,740
Operating Profit
Operating ProfitCr
1701561357712322432728624499142169
OPM
OPM%
16.914.612.97.911.118.121.317.113.46.07.78.8
Other Income
Other IncomeCr
245623222160137
Interest Expense
Interest ExpenseCr
1262421262214253866122127
Depreciation
DepreciationCr
616368727173797192114126133
PBT
PBTCr
999148-929132237193136-74-10746
Tax
TaxCr
17147-64398251394-814
PAT
PATCr
827741-3249315514297-78-9932
Growth
PAT Growth%
-1.1-6.0-46.6-107.1930.5285.866.4-8.1-31.8-180.4-26.6127.6
NPM
NPM%
8.17.24.0-0.32.27.510.18.55.3-4.7-5.31.7
EPS
EPS₹
8.98.44.5-0.32.610.116.815.410.5-8.5-10.73.4
Sales CAGR
1 Year11%
3 Years3%
5 Years8%
TTM11%
EBITDA CAGR
1 Year43%
3 Years-21%
5 Years-9%
TTM135%
Avg. ROCE
1 Year1%
3 Years3%
5 Years10%
TTM9%
CFO / EBITDA
1 Year136%
3 Years91%
5 Years72%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
181818181818181818181818
Reserves
ReservesCr
5586336576426617518861,0101,0911,0049211,003
Current Liabilities
Current LiabilitiesCr
3033904164464594074254256128081,053972
Non Current Liabilities
Non Current LiabilitiesCr
61155146152133139157205422604609625
Total Liabilities
Total LiabilitiesCr
9411,1971,2361,2581,2721,3151,4861,6582,1452,4302,5932,613
Current Assets
Current AssetsCr
4655725375385636237748149551,0011,1931,226
Non Current Assets
Non Current AssetsCr
4766256997207086937128451,1901,4291,4001,387
Total Assets
Total AssetsCr
9411,1971,2361,2581,2721,3151,4861,6582,1452,4302,5932,613
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
181818181818181818181818
Reserves
ReservesCr
5586336576426617518861,0101,0911,0049211,003
Current Liabilities
Current LiabilitiesCr
3033904164464594074254256128081,053972
Non Current Liabilities
Non Current LiabilitiesCr
61155146152133139157205422604609625
Total Liabilities
Total LiabilitiesCr
9411,1971,2361,2581,2721,3151,4861,6582,1452,4302,5932,613
Current Assets
Current AssetsCr
4655725375385636237748149551,0011,1931,226
Non Current Assets
Non Current AssetsCr
4766256997207086937128451,1901,4291,4001,387
Total Assets
Total AssetsCr
9411,1971,2361,2581,2721,3151,4861,6582,1452,4302,5932,613

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
112891231321238217417915795192
Investing Cash Flow
Investing Cash FlowCr
-111-171-136-104-56-67-121-208-434-339-102
Financing Cash Flow
Financing Cash FlowCr
-2132-39-16-64-30-4423280241-77
Net Cash Flow
Net Cash FlowCr
050-52123-148-73-314
Free Cash Flow
Free Cash FlowCr
1138912513612382175180158-25791
CFO To PAT
CFO To PAT%
137.0115.0298.1-4,549.4509.488.4112.3125.7161.5-121.8-194.8
CFO To EBITDA
CFO To EBITDA%
65.856.691.0172.499.736.753.162.564.195.7135.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
112891231321238217417915795192
Investing Cash Flow
Investing Cash FlowCr
-111-171-136-104-56-67-121-208-434-339-102
Financing Cash Flow
Financing Cash FlowCr
-2132-39-16-64-30-4423280241-77
Net Cash Flow
Net Cash FlowCr
050-52123-148-73-314
Free Cash Flow
Free Cash FlowCr
1138912513612382175180158-25791
CFO To PAT
CFO To PAT%
137.0115.0298.1-4,549.4509.488.4112.3125.7161.5-121.8-194.8
CFO To EBITDA
CFO To EBITDA%
65.856.691.0172.499.736.753.162.564.195.7135.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,6532,3031,9421,8681,9292,6593,4703,0003,0272,1521,5222,143
Price To Earnings
Price To Earnings
32.429.947.179.928.622.421.130.867.7
Price To Sales
Price To Sales
2.62.11.91.91.72.12.31.81.71.30.81.1
Price To Book
Price To Book
4.63.52.92.82.83.53.82.92.72.11.62.1
EV To EBITDA
EV To EBITDA
16.215.916.027.117.013.011.311.615.031.518.218.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.461.460.659.963.064.863.660.459.659.960.360.3
OPM
OPM%
16.914.612.97.911.118.121.317.113.46.07.78.8
NPM
NPM%
8.17.24.0-0.32.27.510.18.55.3-4.7-5.31.7
ROCE
ROCE%
15.910.87.91.26.214.921.616.09.8-0.40.88.6
ROE
ROE%
14.211.86.1-0.43.512.117.113.88.7-7.6-10.53.1
ROA
ROA%
8.76.43.3-0.21.97.110.48.64.5-3.2-3.81.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,6532,3031,9421,8681,9292,6593,4703,0003,0272,1521,5222,143
Price To Earnings
Price To Earnings
32.429.947.179.928.622.421.130.867.7
Price To Sales
Price To Sales
2.62.11.91.91.72.12.31.81.71.30.81.1
Price To Book
Price To Book
4.63.52.92.82.83.53.82.92.72.11.62.1
EV To EBITDA
EV To EBITDA
16.215.916.027.117.013.011.311.615.031.518.218.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.461.460.659.963.064.863.660.459.659.960.360.3
OPM
OPM%
16.914.612.97.911.118.121.317.113.46.07.78.8
NPM
NPM%
8.17.24.0-0.32.27.510.18.55.3-4.7-5.31.7
ROCE
ROCE%
15.910.87.91.26.214.921.616.09.8-0.40.88.6
ROE
ROE%
14.211.86.1-0.43.512.117.113.88.7-7.6-10.53.1
ROA
ROA%
8.76.43.3-0.21.97.110.48.64.5-3.2-3.81.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2,9012,7572,1752,1431,8411,5931,482
Close PriceClose₹1,693.90317.05492.30232.151,655.402,312.00512.65
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE51.4932.4882.4667.6833.9925.87
Price To SalesPS3.343.663.261.124.144.042.80
RevenueRevenueCr8707536681,909444395529
Revenue Growth TTMRev Gr TTM%30.1%10.6%15.2%10.6%12.6%
PAT Growth TTMPAT Gr TTM%-64.3%127.6%27.3%64.3%1.0%
Market CapitalizationMkt CapCr2,9012,7572,1752,1431,8411,5931,482
Close PriceClose₹1,693.90317.05492.30232.151,655.402,312.00512.65
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE51.4932.4882.4667.6833.9925.87
Price To SalesPS3.343.663.261.124.144.042.80
RevenueRevenueCr8707536681,909444395529
Revenue Growth TTMRev Gr TTM%30.1%10.6%15.2%10.6%12.6%
PAT Growth TTMPAT Gr TTM%-64.3%127.6%27.3%64.3%1.0%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews